Efficacy of tezepelumab in adults with severe, uncontrolled chronic rhinosinusitis with nasal polyps and comorbid NSAID-exacerbated respiratory disease (WAYPOINT)

Efficacy of tezepelumab in adults with severe, uncontrolled chronic rhinosinusitis with nasal polyps and comorbid NSAID-exacerbated respiratory disease (WAYPOINT) Meeting Abstract

publication date

September 1, 2025

webpage

Web of Science

published in

EUROPEAN RESPIRATORY JOURNAL Journal

volume

66